Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Oral baricitinib is effective and safe for treating alopecia areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Semaglutide helps obese PCOS patients lose weight and improve health.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.